Point-of-Care Mastoid Fontanelle Ultrasonography for Diagnosis and Bedside Follow-up of Neonatal Transverse Sinus Thrombosis: A Case Report.

J Clin UltrasoundApr 5, 2026 (epub)
Case ReportPediatricsNeurologyOpen access

Nazan Neslihan Dogan Kocabıyık, Cagin Huryol, Ecem Esra Erol et al.

✦ AI-curated · Sources linked

Case in brief

A preterm neonate presented with apnea and later developed focal neurological deficits. Anterior fontanelle ultrasonography was unremarkable, but point-of-care mastoid fontanelle ultrasonography showed markedly reduced venous flow in the right transverse sinus, prompting suspicion of thrombosis. MRI with venography confirmed neonatal cerebral venous sinus thrombosis. During anticoagulant therapy, serial bedside mastoid fontanelle ultrasonography showed thrombus regression, with findings concordant with MRI/MRV.

What made this case unusual

The anterior fontanelle study was unremarkable, whereas mastoid fontanelle ultrasonography detected reduced flow in the affected transverse sinus and also supported bedside follow-up.

Diagnostic / clinical pearl

In a neonate with suspected cerebral venous sinus thrombosis, mastoid fontanelle ultrasonography may complement anterior fontanelle imaging and provide bedside monitoring; MRI with venography confirmed the diagnosis in this case.

Source

Published in J Clin Ultrasound. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.